Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.39 -0.05 (-3.47%)
As of: Nov 11, 2026 · 11:03 AM EST

Cadrenal Therapeutics (CVKD) Shares Outstanding (Entity) (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) recorded Shares Outstanding (Entity) of 3.1 million in Q2 2026, up 54.4% from 2.01 million a year earlier and up 23.6% from the prior quarter.

Analysis

Cadrenal Therapeutics (CVKD) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends

For FY2025, Cadrenal Therapeutics reported Shares Outstanding (Entity) of 2.34 million, up 91.7% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for three straight years, with a three-year compound annual growth rate of 62.4% (FY2022 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 1.22 million in FY2024 (+40.5%), 868,227 in FY2023 (+58.9%) and 546,286 in FY2022.
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2022.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for 14 consecutive quarters, with growth averaging 61.7% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 31.3% in Q1 2026 to 91.7% in Q4 2025.
  • Per Business Quant, the preceding three quarters came in at 2.51 million (Q1 2026), 2.34 million (Q4 2025) and 2.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 940.75 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 540.90 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.24 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.70 Bn
10 Cadrenal Therapeutics 557,746.58 -12.06 Mn - 387,324.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 387,324.00
Mar 31, 2026 417,803.00
Dec 31, 2025 389,688.00
Sep 30, 2025 343,292.00
Jun 30, 2025 334,519.00
Mar 31, 2025 318,289.00
Dec 31, 2024 203,258.00
Sep 30, 2024 205,779.00
Jun 30, 2024 177,881.00
Mar 31, 2024 177,881.00
Dec 31, 2023 144,704.00
Sep 30, 2023 144,704.00
Jun 30, 2023 130,259.00
Mar 31, 2023 130,259.00
Dec 31, 2022 91,048.00
Sep 30, 2022 90,303.00
Jun 30, 2022 88,338.00
Mar 31, 2022 83,338.00
API Access

Cadrenal Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CVKD&period=max&api_key=YOUR_API_KEY